Zobrazeno 1 - 10
of 13
pro vyhledávání: '"A. D. Manthripragada"'
Autor:
Paul D. Miller, A. D. Manthripragada, J. W. Hall, Ugis Gruntmanis, Cynthia D. O'Malley, Rachel B. Wagman
Publikováno v:
Osteoporosis International. 26:1619-1627
In this large retrospective study of men with presumed osteoporosis, we estimate the rate of osteoporosis-related fractures in men age ≥30 years. Our results suggest that spine and hip fractures continue to be a considerable disease burden for oste
Autor:
Simone P. Pinheiro, Angelika D Manthripragada, Chris Worrall, Jeffrey A. Kelman, Thomas E. MaCurdy, David J. Graham, Shahin Saneinejad
Publikováno v:
Pediatrics. 132:e1327-e1332
OBJECTIVE: To assess off-label use of the topical calcineurin inhibitors (TCIs), tacrolimus and pimecrolimus, in children during periods before and after regulatory action by the US Food and Drug Administration (FDA) in 2005. METHODS: We identified n
Autor:
Mary E. Willy, Esther H. Zhou, Daniel S. Budnitz, Maribeth C. Lovegrove, Angelika D. Manthripragada
Publikováno v:
Pharmacoepidemiology and Drug Safety. 20:819-826
PURPOSE: To estimate the number of acetaminophen overdose-related emergency department (ED) visits and hospitalizations in the United States, characterize these by intentionality, age, and gender, and compare the strengths and limitations of the util
Autor:
S. K. Van Den Eeden, F. Kamel, Caroline M. Tanner, G. W. Ross, David M. Umbach, Karen Marder, Beate Ritz, Barbara Topol, Angelika D. Manthripragada, Lorene M. Nelson, Richard Mayeux, Richard M. Myers, Audrey Southwick, Helen Petrovitch, Valerie McGuire, Sadie Costello, Rita A. Popat
Publikováno v:
European Journal of Neurology. 18:756-765
Objective In MPTP animal models of Parkinson’s disease (PD), caffeine protects neurons by blocking the adenosine receptor A2A (ADORA2A). Caffeine is primarily metabolized by cytochrome P450 1A2 (CYP1A2). Our objective was to examine whether ADORA2A
Autor:
Jørgen H. Olsen, Lene Wermuth, Søren Friis, Lei Qian, Eva S. Schernhammer, Beate Ritz, Angelika D. Manthripragada
Publikováno v:
Ritz, B, Manthripragada, A D, Qian, L, Schernhammer, E, Wermuth, L, Olsen, J & Friis, S 2010, ' Statin use and Parkinson's disease in Denmark ', Movement Disorders, vol. 25, no. 9, pp. 1210-6 . https://doi.org/10.1002/mds.23102
The objective of this study was to investigate whether statin (3-hydroxy-3-methylglutaryl-coenzyme A reductase inhibitor) use is associated with risk of Parkinson's disease (PD) in Denmark. We identified 1,931 patients with a first time diagnosis of
Publikováno v:
Epidemiology. 21:87-94
Background: Human, animal and cell models support a role for pesticides in the etiology of Parkinson disease. Susceptibility to pesticides may be modified by genetic variants of xenobiotic enzymes, such as paraoxonase, that play a role in metabolizin
Publikováno v:
Environmental Health Perspectives
Epidemiologic studies since the early 1990s have suggested that exposure to various classes of pesticides increases the risk of developing Parkinson’s disease (PD). Animal studies have backed up that link, revealing how pesticides may target the do
Autor:
Myles Cockburn, Beate Ritz, Matthew J. Farrer, Angelika D. Manthripragada, Sadie Costello, Sarah Lincoln, Jeff M. Bronstein
Publikováno v:
Environmental Health Perspectives
Background Research suggests that independent and joint effects of genetic variability in the dopamine transporter (DAT) locus and pesticides may influence Parkinson’s disease (PD) risk. Materials Methods: In 324 incident PD patients and 334 popula
Autor:
R A, Popat, S K, Van Den Eeden, C M, Tanner, F, Kamel, D M, Umbach, K, Marder, R, Mayeux, B, Ritz, G W, Ross, H, Petrovitch, B, Topol, V, McGuire, S, Costello, A D, Manthripragada, A, Southwick, R M, Myers, L M, Nelson
Publikováno v:
European journal of neurology. 18(5)
In 1-methyl-4-phenyl 1,2,3,6-tetrahydropyridine animal models of Parkinson's disease (PD), caffeine protects neurons by blocking the adenosine receptor A2A (ADORA2A). Caffeine is primarily metabolized by cytochrome P450 1A2 (CYP1A2). Our objective wa
Autor:
Lene Wermuth, Eva S. Schernhammer, Søren Friis, Jørgen H. Olsen, Beate Ritz, Angelika D. Manthripragada, Jiaheng Qiu
Publikováno v:
Manthripragada, A D, Schernhammer, E S, Qiu, J, Friis, S, Wermuth, L, Olsen, J H & Ritz, B 2011, ' Non-steroidal anti-inflammatory drug use and the risk of Parkinson's disease ', Neuroepidemiology, vol. 36, no. 3, pp. 155-61 . https://doi.org/10.1159/000325653
Background: Experimental evidence supports a preventative role for non-steroidal anti-inflammatory drugs (NSAIDs) in Parkinson’s disease (PD). Methods: We investigated associations between use of aspirin, nonaspirin NSAIDs, and acetaminophen and PD